Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Andreas R. Gantenbein
Sort by Type
Date
Speaker
ePoster
P082
Impact of Atogepant on achieving complete improvement as early as week 1 based on the Activity impairment in Migraine-Diary (AIM-D) domains: post hoc analysis from the ADVANCE, ELEVATE, and PROGRESS trials
Further involvements
ePoster
P076
Impact of Atogepant on daily functioning in patients with episodic migraine and chronic migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level analysis
ePoster
P082
Impact of Atogepant on achieving complete improvement as early as week 1 based on the Activity impairment in Migraine-Diary (AIM-D) domains: post hoc analysis from the ADVANCE, ELEVATE, and PROGRESS trials
ePoster
P148
Fremanezumab for the prevention of menstrually-related migraine attacks – a prospective observational phase 4 study according to routine neurological care in Switzerland (FROMM)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy